Carbinoxamine maleate 0.4 mg/mL / dextromethorphan hydrobromide 3 mg/mL / pseudoephedrine hydrochloride 3 mg/mL Oral Solution
RxNorm 1013017
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1013017 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbinoxamine maleate 0.4 mg/mL / dextromethorphan hydrobromide 3 mg/mL / pseudoephedrine hydrochloride 3 mg/mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbinoxamine maleate 0.4 mg/ML / dextromethorphan hydrobromide 3 mg/ML / pseudoephedrine hydrochloride 3 mg/ML Oral Solution
(Atom ID: 12331835)
PSN
Prescribable Name (PSN):
Carbinoxamine maleate 0.4 mg/mL / dextromethorphan hydrobromide 3 mg/mL / pseudoephedrine hydrochloride 3 mg/mL Oral Solution
(Atom ID: 12515820)
SY